DRK Kliniken Berlin — Clinical Trial Site

42 Registered trials

21 Currently recruiting

Organisation

DRK Kliniken Berlin

Location

Berlin, Germany

Identifier

ORG-100025846

Address

Spandauer Damm 130, 14050, Germany

Departments

Berliner Adipositaszentrum
Brustzentrum
Brustzentrum Köpenick
Cardiology
Clinic for general, visceral and minimally invasive surgery
Clinic for Internal Medicine - Cardiology
Clinic for Internal Medicine - Gastroenterology, Hematology and Oncology, Nephrology
Clinic for Internal Medicine-Gastroenterology
Clinic for Internal Medicine, Gastroenterology
Darmzentrum Köpenick
Department of Hematology/Oncology
Department of Internal Medicine, Gastroenterology
DRK Kliniken Berlin Westend Medizinische Klinik II
DRK-Kliniken Berlin Westend Klinik f. lnnere Medizin - Gastroenterologie
Early Phase Clinical Unit (EPCU) Berlin
Gastroenterology
Klinik fuer Innere Medizin
Klinik fuer Innere Medizin II
Klinik für Gynäkologie
Klinik für Gynäkologie und Geburtshilfe
Klinik für Innere Medizin
Klinik für Innere Medizin - Gastroenterologie, Hämatologie und Onkologie, Nephrologie
Klinik für Innere Medizin - Kardiologie
Klinik für Innere Medizin mit SP Gastro-, Hämato-und Onkologie
Medizinische Klinik II
N/A
NA
Oncology
Studienbüro / Kardiologie
Studienbüro/ Kardiologie/ Hochhaus 6. Etage

Clinical trials at this site (42)

Search interface

A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038) Ended

2025-521970-33-00 Pulmonary Arterial Hypertension (PAH) 5 2025-12-19
A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended

2025-522598-12-00 Untreated Metastatic Pancreatic Ductal Adenocarcinoma 10 2025-12-17
A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended

2024-518998-33-00 Ulcerative Colitis 5 2025-07-23
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
A study to test the effect of BI 456906 on cardiovascular safety in people with overweight or obesity Ended

2022-502442-27-00 Obesity 5 2024-01-08
Multicenter, prospective, double-blind, randomized, three-armed, placebo-controlled study of long-term therapeutic transfer of encapsulated … Ended

2024-517132-22-00 active ulcerative colitis 5 2023-01-26
PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controll… Ended

2024-511321-54-00 intermediate-high-risk acute pulmonary embolism 5 2021-08-04
"Clinical Study of Inhaled GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)" Ended

2024-516754-22-00 Pulmonary Arterial Hypertension (PAH) 4 2021-07-14
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis Ended

2023-506994-36-00 Ulcerative Colitis 5 2018-10-11
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the … Ended

2023-503614-80-00 Pulmonary Arterial Hypertension 5 2023-12-14
A Study to Investigate Bowel Urgency in Adults with Moderately to Severely Active Ulcerative Colitis Treated with Mirikizumab Ended

2022-502393-16-00 Moderately to Severely Active Ulcerative Colitis 5 2023-09-06
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer Ended

2022-502267-37-00 metastatic colorectal cancer 9 2023-07-17
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 Moderately to severely active ulcerative colitis 5 2023-06-08
A study to evaluate the effects of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertension with Interstitial Lun… Ended

2023-505540-19-00 Pulmonary Hypertension Associated with Interstitial Lun 10 2023-04-24
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients. Ended

2023-509139-16-00 Therapeutic confirmatory (phase III) 5 2022-05-13
A Phase 2 Study of Sotatercept for Combined Postcapillary and Precapillary Pulmonary Hypertension Treatment Ended

2023-509141-12-00 Combined Postcapillary and Precapillary Pulmonary Hyper 4 2022-04-28
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04